Feduchi E, Carrasco L
Centro de Biología Molecular (CSIC-UAM), Universidad Autónoma, Madrid, Spain.
Virology. 1991 Feb;180(2):822-5. doi: 10.1016/0042-6822(91)90100-p.
Tumor necrosis factor (TNF) synergizes with interferon (IFN gamma) in the blockade of HSV-1 replication. Antibodies against IFN beta block this synergism, implying a role of IFN beta in the antiviral activity of TNF plus IFN gamma. IFN beta 1 added exogenously to Hep-2 cells shows antiviral activity against HSV-1 only at high concentrations, whereas IFN beta 2 (also known as IL-6) alone has no effect on the replication of VSV or HSV-1 even when 1,000 U/ml are present. Our results are in accordance with the idea that TNF induces IFN beta 1 and that both cytokines must be present in the culture medium to synergize with IFN gamma in order to inhibit HSV-1 replication.
肿瘤坏死因子(TNF)与干扰素(IFNγ)协同作用,阻断单纯疱疹病毒1型(HSV-1)的复制。抗IFNβ抗体可阻断这种协同作用,这意味着IFNβ在TNF加IFNγ的抗病毒活性中发挥作用。外源性添加到Hep-2细胞中的IFNβ1仅在高浓度时才显示出对HSV-1的抗病毒活性,而单独的IFNβ2(也称为IL-6)即使存在1000 U/ml也对水泡性口炎病毒(VSV)或HSV-1的复制没有影响。我们的结果符合以下观点:TNF诱导IFNβ1,并且两种细胞因子必须同时存在于培养基中才能与IFNγ协同作用,从而抑制HSV-1的复制。